{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:14:19Z","timestamp":1790784859291,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013280","name":"Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["2023AH050682"],"award-info":[{"award-number":["2023AH050682"]}],"id":[{"id":"10.13039\/501100013280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2021xkjT025"],"award-info":[{"award-number":["2021xkjT025"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304382"],"award-info":[{"award-number":["82304382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bcp.2026.117761","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:07:00Z","timestamp":1769818020000},"page":"117761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Momordin\u00a0Ic suppresses breast cancer growth by targeting ACTL8\u2011dependent glutamine metabolism and PI3K\/AKT\/mTOR\u2013MYC"],"prefix":"10.1016","volume":"247","author":[{"given":"Ao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aolin Xiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinlin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunwen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.117761_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.bcp.2026.117761_b0010","first-page":"524","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"10286","key":"10.1016\/j.bcp.2026.117761_b0015","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bcp.2026.117761_b0020","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.bcp.2026.117761_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115464","article-title":"Glutamine metabolism in breast cancer and possible therapeutic targets","volume":"210","author":"Li","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117761_b0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.117761_b0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","article-title":"Glutaminolysis: a hallmark of cancer metabolism","volume":"19","author":"Yang","year":"2017","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.bcp.2026.117761_b0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"issue":"7239","key":"10.1016\/j.bcp.2026.117761_b0045","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2026.117761_b0050","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bcp.2026.117761_b0055","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nrc.2016.131","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2026.117761_b0060","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.117761_b0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in Cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.117761_b0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2026.117761_b0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.117761_b0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/2326-6066.CIR-13-0088","article-title":"Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers","volume":"2","author":"Yao","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"15","key":"10.1016\/j.bcp.2026.117761_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153875","article-title":"Cancer-testis antigens in triple-negative breast cancer: role and potential utility in clinical practice","volume":"13","author":"Lam","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.117761_b0090","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2147\/OTT.S291403","article-title":"Actin-like protein 8 promotes the progression of triple-negative breast cancer via activating PI3K\/AKT\/mTOR pathway","volume":"14","author":"Fan","year":"2021","journal-title":"Onco Targets Ther."},{"issue":"19","key":"10.1016\/j.bcp.2026.117761_b0095","article-title":"Identification of a novel prognostic model for gastric cancer utilizing glutamine-related genes","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2026.117761_b0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.bcp.2026.117761_b0105","doi-asserted-by":"crossref","first-page":"18110","DOI":"10.1038\/s41598-024-69185-x","article-title":"Comprehensive analysis of sialylation-related genes and construct the prognostic model in sepsis","volume":"14","author":"Tao","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2026.117761_b0110","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117761_b0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.bcp.2026.117761_b0120","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.21037\/tcr.2019.09.33","article-title":"Knockdown of actin-like 8 inhibits cell proliferation by regulating FOXM1, STMN1, PLK1, and BIRC5 in lung adenocarcinoma A549 cells","volume":"8","author":"Ma","year":"2019","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117761_b0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-024-02095-6","article-title":"Redox regulation: mechanisms, biology and therapeutic targets in diseases","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.117761_b0130","first-page":"877","article-title":"High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma","volume":"19","author":"Li","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2026.117761_b0135","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1007\/s10620-024-08649-6","article-title":"ACTL8 promotes the progression of gastric cancer through PI3K\/AKT\/mTOR signaling pathway","volume":"69","author":"Yu","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bcp.2026.117761_b0140","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2147\/OTT.S185858","article-title":"Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer","volume":"12","author":"Han","year":"2019","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.bcp.2026.117761_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101708","article-title":"Actin-like protein 8, a member of cancer\/testis antigens, supports the aggressive development of oral squamous cell carcinoma cells via activating cell cycle signaling","volume":"75","author":"Wang","year":"2022","journal-title":"Tissue Cell"},{"issue":"3","key":"10.1016\/j.bcp.2026.117761_b0150","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/1759-7714.13247","article-title":"Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells","volume":"11","author":"Ma","year":"2020","journal-title":"Thorac Cancer."},{"issue":"3","key":"10.1016\/j.bcp.2026.117761_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrm3522","article-title":"Amino acid signalling upstream of mTOR","volume":"14","author":"Jewell","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117761_b0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2026.117761_b0165","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer."},{"issue":"9","key":"10.1016\/j.bcp.2026.117761_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185092","article-title":"Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition","volume":"12","author":"Lampa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.117761_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1143798","article-title":"Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer","volume":"13","author":"Ni","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117761_b0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jphs.2021.04.007","article-title":"Momordin Ic induces G0\/1 phase arrest and apoptosis in colon cancer cells by suppressing SENP1\/c-MYC signaling pathway","volume":"146","author":"Xianjun","year":"2021","journal-title":"J. Pharmacol. Sci."},{"issue":"37","key":"10.1016\/j.bcp.2026.117761_b0185","doi-asserted-by":"crossref","first-page":"58995","DOI":"10.18632\/oncotarget.10636","article-title":"Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.117761_b0190","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.freeradbiomed.2015.11.022","article-title":"Momordin Ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K\/Akt and MAPK signaling pathways","volume":"90","author":"Mi","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117761_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104784","article-title":"Natural triterpenoid saponin Momordin Ic suppresses HepG2 cell invasion via COX-2 inhibition and PPAR\u03b3 activation","volume":"65","author":"Wang","year":"2020","journal-title":"Toxicol. In Vitro"},{"issue":"2","key":"10.1016\/j.bcp.2026.117761_b0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2026.117761_b0205","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jare.2025.01.035","article-title":"Ailanthone induces triple-negative breast cancer cells death involving the inhibition of OTUB1-mediated ERR\u03b1 deubiquitylation","volume":"77","author":"Zhang","year":"2025","journal-title":"J. Adv. Res."},{"issue":"49","key":"10.1016\/j.bcp.2026.117761_b0210","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bcp.2026.117761_b0215","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:08:24Z","timestamp":1779109704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"alternative-id":["S0006295226000924"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117761","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Momordin\u00a0Ic suppresses breast cancer growth by targeting ACTL8\u2011dependent glutamine metabolism and PI3K\/AKT\/mTOR\u2013MYC","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117761"}}